Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lewy Body Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03924414
What this trial is testing

Trial of Parkinson's And Zoledronic Acid

Who this might be right for
Parkinson DiseaseOsteoporosisParkinsonism+6 more
California Pacific Medical Center Research Institute 2,721
Testing effectiveness (Phase 2)UnknownNCT05505877
What this trial is testing

Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Gopherwood Biotech Co., Ltd. 160
Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Testing effectiveness (Phase 2)Study completedNCT04739423
What this trial is testing

Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

Who this might be right for
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
CuraSen Therapeutics, Inc. 41
Testing effectiveness (Phase 2)UnknownNCT04167813
What this trial is testing

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

Who this might be right for
Parkinson's HallucinationsDementia With Lewy Bodies
University College, London 168
Large-scale testing (Phase 3)Looking for participantsNCT06952504
What this trial is testing

Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 1,123
Early research (Phase 1)Not Yet RecruitingNCT06607900
What this trial is testing

HUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+3 more
Xuanwu Hospital, Beijing 120
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT04483219
What this trial is testing

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Who this might be right for
MSSpMMRMetastatic Colorectal Adenocarcinoma
China Medical University, China 53
Not applicableLooking for participantsNCT06629207
What this trial is testing

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Who this might be right for
Parkinson DiseaseREM Sleep Behavior DisorderDementia, Lewy Body
Insel Gruppe AG, University Hospital Bern 20
Not applicableEnrolling By InvitationNCT07595666
What this trial is testing

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Who this might be right for
DementiaMovement DisordersALS - Amyotrophic Lateral Sclerosis+11 more
prof. dr. Koen Van Laere 1,600
Testing effectiveness (Phase 2)Study completedNCT03993353
What this trial is testing

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more
University of California, San Diego 7
Not applicableEnded earlyNCT04020198
What this trial is testing

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Who this might be right for
Parkinson DiseaseMultiple System AtrophyRapid Eye Movement Sleep Behavior Disorder+1 more
Stony Brook University 8
Not applicableActive Not RecruitingNCT05014971
What this trial is testing

Telehealth in Lewy Body Dementia

Who this might be right for
Lewy Body Dementia With Behavioral DisturbanceLewy Body Parkinson DiseaseLewy Body Disease
University of Florida 106
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Large-scale testing (Phase 3)Study completedNCT03898180
What this trial is testing

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

Who this might be right for
Urothelial Carcinoma
Merck Sharp & Dohme LLC 505
Not applicableStudy completedNCT03043768
What this trial is testing

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
GWT-TUD GmbH 50
Not applicableLooking for participantsNCT07644013
What this trial is testing

Prospective Multicenter Registry Study of Multiple System Atrophy in China

Who this might be right for
Multiple System AtrophyParkinson's DiseaseAtypical Parkinsonism
Peking University First Hospital 214
Large-scale testing (Phase 3)WithdrawnNCT04859582
What this trial is testing

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension

Who this might be right for
Stomach Neoplasms
Merck Sharp & Dohme LLC
Next Page